350 related articles for article (PubMed ID: 31608751)
1. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
Iocolano M; Wild AT; Hannum M; Zhang Z; Simone CB; Gelblum D; Wu AJ; Rimner A; Shepherd AF
Acta Oncol; 2020 Feb; 59(2):164-170. PubMed ID: 31608751
[No Abstract] [Full Text] [Related]
2. Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
Zayed S; Chen H; Ali E; Rodrigues GB; Warner A; Palma DA; Louie AV
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):575-586. PubMed ID: 32544575
[TBL] [Abstract][Full Text] [Related]
3. Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
Jacobs CD; Gao J; Wang X; Clarke JM; Tong B; Ready NE; Suneja G; Kelsey CR; Torok JA
Clin Lung Cancer; 2020 May; 21(3):238-246. PubMed ID: 31757764
[TBL] [Abstract][Full Text] [Related]
4. Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer.
Saeed NA; Jin L; Amini A; Verma V; Lester-Coll NH; Chen PH; Decker RH; Park HS
Am J Clin Oncol; 2023 Feb; 46(2):66-72. PubMed ID: 36662872
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Stahl JM; Ross R; Harder EM; Mancini BR; Soulos PR; Finkelstein SE; Shafman TD; Dosoretz AP; Evans SB; Husain ZA; Yu JB; Gross CP; Decker RH
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1011-1020. PubMed ID: 27869080
[TBL] [Abstract][Full Text] [Related]
6. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of the CHIRP Trial: A Phase II Prospective Randomized Trial of Conventionally Fractionated Versus Moderately Hypofractionated Prostate and Pelvic Nodal Radiation Therapy in Patients With High-Risk Prostate Cancer.
Wang MH; Vos LJ; Yee D; Patel S; Pervez N; Parliament M; Usmani N; Danielson B; Amanie J; Pearcey R; Ghosh S; Field C; Fallone BG; Murtha AD
Pract Radiat Oncol; 2021; 11(5):384-393. PubMed ID: 33705985
[TBL] [Abstract][Full Text] [Related]
9. Stage I Lung SBRT Clinical Practice Patterns.
Corso CD; Park HS; Moreno AC; Kim AW; Yu JB; Husain ZA; Decker RH
Am J Clin Oncol; 2017 Aug; 40(4):358-361. PubMed ID: 25503436
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma.
Lyu J; Liu T; Li T; Li F; Wang Q; Wang J; Han Y; Wang J; Zhang J; Peng L; Lang J
Cancer Med; 2019 Jul; 8(8):3710-3718. PubMed ID: 31119872
[TBL] [Abstract][Full Text] [Related]
11. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S
J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790
[TBL] [Abstract][Full Text] [Related]
12. Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction).
Valeriani M; Marinelli L; Nicosia L; Reverberi C; De Sanctis V; Mollo D; Osti MF
Radiol Med; 2019 Dec; 124(12):1324-1332. PubMed ID: 31317381
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?
Bott MJ; Patel AP; Verma V; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1549-1558.e2. PubMed ID: 27207124
[TBL] [Abstract][Full Text] [Related]
14. Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer.
Kong C; Zhu X; Shi M; Wang L; Chen C; Tao H; Jiang N; Yan P; Zhao L; Song X; He X
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):710-719. PubMed ID: 32275994
[TBL] [Abstract][Full Text] [Related]
15. Impact of Peer Review on Use of Hypofractionated Regimens for Early-Stage Breast Cancer for Patients at a Tertiary Care Academic Medical Center and Its Community-Based Affiliates.
Ganju RG; TenNapel M; Chen AM; Mitchell M
J Oncol Pract; 2019 Feb; 15(2):e153-e161. PubMed ID: 30625021
[TBL] [Abstract][Full Text] [Related]
16. Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer.
Amini A; Lin SH; Wei C; Allen P; Cox JD; Komaki R
Radiat Oncol; 2012 Mar; 7():33. PubMed ID: 22420631
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy with higher biologically effective dose is associated with improved survival in stage II non-small cell lung cancer.
Yan SX; Qureshi MM; Dyer M; Truong MT; Mak KS
Lung Cancer; 2019 May; 131():147-153. PubMed ID: 31027693
[TBL] [Abstract][Full Text] [Related]
18. Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.
Xiang M; Chang AJ; Chamie K; Drakaki A; Pollom EL; Steinberg ML; Kishan AU
Clin Genitourin Cancer; 2022 Apr; 20(2):e94-e103. PubMed ID: 34866018
[TBL] [Abstract][Full Text] [Related]
19. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
Wang L; Correa CR; Zhao L; Hayman J; Kalemkerian GP; Lyons S; Cease K; Brenner D; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1383-90. PubMed ID: 18929449
[TBL] [Abstract][Full Text] [Related]
20. The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients.
Wang SJ; Jhawar SR; Rivera-Nunez Z; Silk AW; Byun J; Miller E; Blakaj D; Parikh RR; Weiner J; Goyal S
Cureus; 2020 Jun; 12(6):e8767. PubMed ID: 32714704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]